Lancet Neurology

The Lancet Neurology is a premier, peer-reviewed clinical journal within the esteemed Lancet family, published by Elsevier. Holding an exceptional Journal Impact Factor of 54.600 and ranking in the top quartile (Q1) of its category, it stands as one of the most authoritative and influential publications in the neurological sciences. The journal’s scope is comprehensive, covering all aspects of clinical neurology, with a particular emphasis on high-impact translational research that bridges the gap between laboratory discovery and patient care. Its core topics span the full spectrum of neurological disorders, including stroke, multiple sclerosis, dementia (such as Alzheimer’s and Parkinson’s disease), epilepsy, migraine, movement disorders, neuromuscular diseases, and neuro-oncology. The Lancet Neurology publishes a curated mix of article types, including original research articles (often large-scale randomized controlled trials and cohort studies), authoritative reviews, personal views, and clinically focused commissions and series. It is also renowned for its incisive news, commentaries, and the influential “In Context” section, which explores global health policy and practice. The target audience is primarily specialist neurologists, neurosurgeons, psychiatrists, and other clinicians managing neurological conditions, as well as academic researchers and policymakers seeking the highest quality evidence. While the journal is subscription-based, selected articles are frequently made open access, and authors may choose open-access publication options. Its consistently top-tier impact factor and rigorous editorial standards—rejecting the vast majority of submissions—affirm its standing as an indispensable resource for the latest, most consequential developments in clinical neurology worldwide.